Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RAS Wild-type Colon Cancer”

126 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 126 results

Early research (Phase 1)Ended earlyNCT03275974
What this trial is testing

Glutamine PET Imaging Colorectal Cancer

Who this might be right for
RAS Wild TypeStage IV Colorectal CancerStage IVA Colorectal Cancer+1 more
M.D. Anderson Cancer Center 6
Not applicableStudy completedNCT02624895
What this trial is testing

ObservationaL Study on the Qol of RAS Wild-type mCRC Patients Receiving Anti-EGFR MAbs + FOLFOX or FOLFIRI as 1st Line

Who this might be right for
Metastatic Colorectal Cancer
Amgen 296
Large-scale testing (Phase 3)UnknownNCT05948072
What this trial is testing

Cetuximab+mFOLFOX6 VS. mFOLFOX6 Alone in RAS/BRAF Wild Type Patients With High-Risk Resectable CRLM

Who this might be right for
Colorectal CancerLiver Metastases
Fudan University 250
Testing effectiveness (Phase 2)Study completedNCT05278728
What this trial is testing

Phase IIa Study of Nimotuzumab to Treat Colorectal Cancer

Who this might be right for
Colorectal Cancer
Biotech Pharmaceutical Co., Ltd. 31
Testing effectiveness (Phase 2)Study completedNCT01251536
What this trial is testing

Cetuximab Standard or Dose Escalation in First Line Colorectal Cancer

Who this might be right for
Colorectal Cancer
Universitaire Ziekenhuizen KU Leuven 108
Testing effectiveness (Phase 2)Ended earlyNCT01540344
What this trial is testing

Combined Anticancer Treatment of Advanced Colon Cancer

Who this might be right for
Peritoneal CarcinomatosisColorectal Cancer Metastatic
University of Regensburg 26
Large-scale testing (Phase 3)Active Not RecruitingNCT04776655
What this trial is testing

Study in mCRC Patients RAS/BRAF wt Tissue and RAS Mutated LIquid BIopsy to Compare FOLFIRI Plus CetuxiMAb or BevacizumaB

Who this might be right for
Colorectal CancerMetastatic Colorectal CancerRAS Mutation
Azienda USL Reggio Emilia - IRCCS 280
Testing effectiveness (Phase 2)Study completedNCT05468892
What this trial is testing

Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO Trial

Who this might be right for
Metastatic Colon Cancer
University of Campania Luigi Vanvitelli 68
Large-scale testing (Phase 3)Study completedNCT04835142
What this trial is testing

Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC

Who this might be right for
Metastatic Colorectal Cancer
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. 688
Large-scale testing (Phase 3)UnknownNCT04262635
What this trial is testing

Cetuximab Plus Capecitabine as Maintenance Treatment in RAS and BRAF wt Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Sun Yat-sen University 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07683403
What this trial is testing

Savolitinib Plus Cetuximab and FOLFOX Chemotherapy for RAS/BRAF Wild-type Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer (CRC)
Fudan University 138
Large-scale testing (Phase 3)Looking for participantsNCT06509126
What this trial is testing

Intermittent or Continuous Panitumumab Plus FOLFIRI for Left Sided RAS/B-RAF Wild-type Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Stage IV
National Cancer Institute, Naples 500
Testing effectiveness (Phase 2)Study completedNCT01215539
What this trial is testing

Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer
Hellenic Cooperative Oncology Group 78
Testing effectiveness (Phase 2)Study completedNCT01312857
What this trial is testing

Study of Hepatic Arterial Infusion With Intravenous Irinotecan, 5FU and Leucovorin With or Without Panitumumab, in Patients With Wild Type RAS Who Have Resected Hepatic Metastases From Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Memorial Sloan Kettering Cancer Center 75
Testing effectiveness (Phase 2)UnknownNCT05291156
What this trial is testing

CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy

Who this might be right for
Metastatic Colorectal Cancer
University of Campania Luigi Vanvitelli 173
Testing effectiveness (Phase 2)Ended earlyNCT01060423
What this trial is testing

TACE With Irinotecan Drug-eluting Beads and Intravenous (IV) Cetuximab in Refractory Colorectal Cancer

Who this might be right for
Colorectal Cancer
Hans-Joachim Schmoll, MD 8
Testing effectiveness (Phase 2)Study completedNCT04787341
What this trial is testing

PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence

Who this might be right for
Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 213
Testing effectiveness (Phase 2)Looking for participantsNCT06776757
What this trial is testing

Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center 30
Large-scale testing (Phase 3)Study completedNCT03231722
What this trial is testing

First Line mFOLFOXIRI + PANITUMUMAB vs mFOLFOX + PANITUMUMAB IN RAS AND BRAF WT METASTATIC COLORECTAL CANCER PATIENTS

Who this might be right for
Metastatic Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 435
Large-scale testing (Phase 3)UnknownNCT05074966
What this trial is testing

The Efficacy and Safety of Modified XELOX(mXELOX) Plus Cetuximab vs FOLFOX Plus Cetuximab in RAS and BRAF WT mCRC Pts

Who this might be right for
Colo-rectal Cancer
Chinese Academy of Medical Sciences 314
Next Page